Quick Answer
Dianthus Therapeutics, Inc. /DE/ reported Net Income of -$162.34 million for fiscal year 2025.
Dianthus Therapeutics, Inc. /DE/ Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$162.34M | -91.1% |
| 2024 | -$84.97M | -95.1% |
| 2023 | -$43.55M | -53.0% |
| 2022 | -$28.48M | +60.0% |
| 2021 | -$71.14M | +5.1% |
| 2020 | -$74.94M | +2.4% |
| 2019 | -$76.77M | -33.5% |
| 2018 | -$57.52M | -62.1% |
| 2017 | -$35.49M | -276.3% |
| 2016 | -$9.43M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$36.77M | -46.0% | -16.2% |
| June 30, 2025 | -$31.63M | -79.6% | -7.2% |
| March 31, 2025 | -$29.51M | -114.7% | -17.2% |
| September 30, 2024 | -$25.17M | -70.5% | -43.0% |
| June 30, 2024 | -$17.61M | -58.1% | -28.1% |
| March 31, 2024 | -$13.75M | -93.9% | +6.9% |
| September 30, 2023 | -$14.76M | -89.7% | -32.5% |
| June 30, 2023 | -$11.14M | -95.6% | -57.1% |
- Dianthus Therapeutics, Inc. /DE/ showed a decrease of -91.1% in Net Income compared to the prior fiscal year.
- Over the 2016–2025 period, Dianthus Therapeutics, Inc. /DE/’s net income has declined by 1621.3% (from -$9.43 million to -$162.34 million).
- The most recent figure is from Dianthus Therapeutics, Inc. /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: